Cellemedy
Seongnam
About Cellemedy
Cellemedy is a biotechnology company committed to developing next-generation therapeutic proteins aimed at replacing conventional antibody treatments. Their proprietary platform offers enhanced antigen-binding capabilities and broader applicability compared to traditional antibodies. Its mission is to advance human health by creating innovative biopharmaceuticals that improve treatment outcomes across various medical conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2023)
- Website: cellemedy.com
- Phone: +82-70-4193-3301
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/cellemedy-119709 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.